Synergy CHC Corp. Announces Third Quarter 2017 Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
487
Synergy CHC Corp. Announces Third Quarter 2017 Results

Westbrook, Maine, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB:  SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, reported results for the quarter ended September 30, 2017.

Quarter 3 2017 and Recent Highlights:

  • Secured $10 million of funding from Knight Therapeutics (Barbados) Inc. with the potential to increase to $30 million
  • Launched The Queen Pegasus, a lash elixir kit sold using The Synergy Effect
  • Hired Robin Mendenhall as Head of Sales – Beauty
  • Hired Jeffrey Kadanoff as Chief Financial Officer
  • Hired Patrick McCullough as President
  • Appointed Gale Bensussen as an independent Board Member
  • Finalized implementation of new systems which will facilitate exponential growth

Net sales for the third quarter were $9.2 million, compared to $11.5 million for the same quarter in 2016, a 20% decrease.  For the third quarter, our net income was $0.01 million or $0.00 (basic and diluted) earnings per share, compared to net income of $3 million or $0.04 (basic and diluted) earnings per share for 2016. 

Net sales for the nine months ended September 30, 2017 were $29.3 million, compared to $28 million for the same period in 2016, a 4.6% increase.  For the nine months ended September 30, 2017, net income was $2.6 million, or $0.03 (basic and diluted) earnings per share, compared to net income of $5.8 million or $0.07 (basic and diluted) earnings per share for the same period in 2016.

We currently focus on Adjusted EBITDA to evaluate our business relationships and our resulting operating performance and financial position. Adjusted EBITDA for the quarter was $1.3 million and for the nine months ended September 30, 2017 it was $5.7 million.

EBITDA and Adjusted EBITDA are considered non-GAAP financial measures. The Company’s definitions of EBITDA and adjusted EBITDA might not be comparable to similarly titled measures reported by other companies.

“The past few months were highlighted by Synergy solidifying its executive team, systems and finances to enable sustained growth in the years to come,” said Jack Ross, CEO of Synergy. “More over with the launch of The Queen Pegasus, this marks the third straight quarter, following Per-fékt Beauty and Sneaky Vaunt, that Synergy added a new brand to its expanding portfolio of products.”

About Synergy CHC Corp.

Synergy CHC Corp. is a consumer health care & beauty company that is in the process of building a portfolio of best-in-class consumer product brands. Synergy’s strategy is to grow its portfolio both organically and by further acquisition. Synergy’s diversified portfolio now includes FOCUSFactor™, Flat Tummy Tea™, Per-fékt Beauty™, Sneaky Vaunt™, The Queen Pegasus™, Neuragen™, and Hand MD™. For more information, please visit www.synergychc.com.

Synergy’s brands:

Flat Tummy Tea ®

Flat Tummy Tea’s uniquely formulated two-step herbal detox tea works to naturally help speed metabolism, boost energy and reduce bloating to flatten your tummy. It is currently sold exclusively online to a global, 20-30 year old female, predominantly American market.

Since being founded in 2013, Flat Tummy Tea has grown rapidly, largely attributed to the strength of their branding and their innovative and effective use of social media. Their secret is a very specific process and ROI based algorithm used on various online platforms. To date, Flat Tummy Tea has built a targeted social media following of over 1,400,000, many of whom are now customers.

Flat Tummy Tea now has over 13,000 positive written reviews on their website, www.flattummyco.com or visit their Instagram page.

FOCUSfactor ®

FOCUSfactor is sold at America’s leading retailers such as Costco, Sam’s Club, Wal-Mart, BJ’s Walgreens, CVS and The Vitamin Shoppe. FOCUSfactor, America’s leading brain health supplement, is a nutritional supplement that includes a proprietary blend of brain supporting vitamins, minerals, antioxidants and other nutrients. In December 2012, the United States Patent and Trademark Office issued US Patent 8,329,227 covering FOCUSfactor’s proprietary formulation “for enhanced mental function.” The issuance of the patent marked one of the few times a patent has been issued for a nationally branded nutritional supplement. FOCUSfactor is clinically tested with results demonstrating improvements in focus, concentration and memory in healthy adults. www.focusfactor.com

Per-fékt Beauty ®

Per-fékt Beauty is one of Synergy's newest brands that was acquired in June of 2017.  Per-fékt Beauty markets and sells a specialized range of beauty products (makeup, skin-care & body) via retailers and online through social media channels.

Per-fékt Beauty is well established in the beauty retail space (Sephora and Ulta), opening up an exciting retail opportunity for the rest of our products in that industry. Even more exciting is the potential to apply the same ROI based algorithm that Flat Tummy Tea uses and is currently being used by The Synergy Effect on various online marketing platforms – what could be more per-fekt?

Per-fékt Beauty be found at perfektbeauty.com or visit their Instagram page.

Sneaky Vaunt ®

Sneaky Vaunt is one of Synergy's newest brands that just launched in March of 2017.  Sneaky Vaunt markets and sells a backless, strapless, stick on, push up bra exclusively online through social media channels.

Sneaky Vaunt is being marketed on the same ROI based algorithm that Flat Tummy Tea uses and is currently being used by The Synergy Effect on various online marketing platforms. In just over six months, Sneaky Vaunt has built a targeted social media following of over 400,000 on Instagram.

Sneaky Vaunt can be found at sneakyvaunt.com or visit their Instagram page.

The Queen Pegasus®

The Queen Pegasus is Synergy's newest brand that just launched in August of 2017.  The Queen Pegasus markets and sells a lash elixir kit exclusively online through social media channels.

The Queen Pegasus is being marketed on the same ROI based algorithm that Flat Tummy Tea and Sneaky Vaunt use and is currently being used by The Synergy Effect on various online marketing platforms.   

The Queen Pegasus can be found at thequeenpegasus.com or visit their Instagram page.

Neuragen ®

Neuragen ® is a topical product that works directly at the site of the pain as opposed to oral products. Neuragen ® reduces the spontaneous firing of damaged peripheral nerves. By calming these firings at the source, Neuragen ® is clinically shown to reduce shooting and burning pains quickly and without the side effects of orally taken medications. This is in part due to the small lipophilic molecules found in Neuragen® which rapidly carry the active ingredients through the rough outer layer of the skin to the site of the pain. Neuragen ® is available over the counter in most local pharmacies either in the diabetic section or the analgesic (pain) section. For more information, please visit www.neuragen.com.

Hand MD ®

Hand MD is the world’s first anti-aging skincare line formulated specifically for the hands. Hands reveal a woman’s true age and the rejuvenation of the hand has become women’s #1 aging concern. Developed by Kara Harshbarger and renowned celebrity dermatologist Dr. Alex Khadavi, Hand MD’s extensive clinical trials show significant improvement in the appearance of fine lines and wrinkles, skin hydration, hyper-pigmentation and radiance. HAND MD launched on QVC and sold out in an astonishing 5 minutes. www.hand-md.com.

The Synergy Effect ®

The Synergy Effect is Synergy’s fast-growth online marketing platform, a growth engine built to grow brands exponentially online. Launched in 2017, The Synergy Effect powers Synergy’s brands online, driving revenue using best-in-class digital strategy and its proprietary ROI algorithm. Already boasting success stories including Flat Tummy Tea and Sneaky Vaunt, both of which have experienced unprecedented growth in digital and social media, The Synergy Effect will spend the upcoming year further unlocking the huge online growth potential within Synergy’s existing portfolio of brands, as well as brands acquired by Synergy. More information on The Synergy Effect can be found at www.thesynergyeffect.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. All statements, other than statements of historical facts, regarding management’s expectations, beliefs, goals, plans or Synergy’s prospects should be considered forward-looking. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including: Synergy’s ability to integrate any new products into its current operations; the risks and uncertainties associated with Synergy’s ability to manage its cash resources; obtaining additional financing to support Synergy’s operations; Synergy’s dependence on third parties for its research and development, manufacturing and distribution functions; Synergy’s dependence on its license relationships; protecting the intellectual property developed by or licensed to Synergy; and Synergy’s ability to build its operations to support its business strategy and promote its products. These and other risks are described in greater detail in Synergy’s filings with the SEC, copies of which are available free of charge at the SEC’s website (www.sec.gov) or upon request from Synergy. Synergy may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. Synergy assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Contact:  Jack Ross, Chairman / CEO Synergy CHC Corp Jack@synergychc.com 615-939-9004

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

HeartCore's Journey: From Nasdaq Challenges to Growth Potential

Updated Category News Views 35

HeartCore's Nasdaq Delisting Challenge HeartCore Enterprises, Inc. (NASDAQ:HTCR), a provider of enterprise software and consulting services, is currently facing a significant challenge related to its listing on the Nasdaq Capital Market. The company has received notice of non-compliance with the minimum bid price requirement, which mandates that its stock price must be at...

Continue Reading
Mitchell Capital Expands Portfolio with Optelos Acquisition

Updated Category News Views 236

Mitchell Capital's New Acquisition of Optelos Mitchell Capital, a prominent private equity firm, recently announced a significant acquisition that marks a pivotal moment for their long-term investment strategy. They have secured a controlling interest in Optelos, a distinguished provider of digital twin platforms that are tailored for enhancing critical infrastructure...

Continue Reading
Tampa Bay Lightning and Scripps Sports Forge Exciting Partnership

Updated Category News Views 247

Partnership Announcement Between Tampa Bay Lightning and Scripps Sports The Tampa Bay Lightning have officially entered into an exciting multi-year partnership with Scripps Sports. This collaboration signifies a new chapter for the Tampa Bay Lightning, expanding their reach in broadcasting and enhancing viewer engagement with National Hockey League (NHL) games. Through...

Continue Reading
Kazia Therapeutics Sets Meeting with FDA on Glioblastoma Treatment

Updated Category News Views 61

Kazia Therapeutics Prepares for FDA Meeting on Paxalisib Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is set to meet with the U.S. Food and Drug Administration (FDA) to explore potential pathways for the registration of its innovative drug, Paxalisib, aimed at treating newly diagnosed glioblastoma multiforme (GBM). This crucial...

Continue Reading
Important Notice for Flux Power Investors on Lead Plaintiff Claims

Updated Category News Views 100

Overview of Flux Power Investor Claims Investors with concerns regarding their investments in Flux Power Holdings, Inc. (NASDAQ: FLUX) have much to consider as recent developments unfold. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims that could impact investor interests and is eager to assist those affected. Critical Investment...

Continue Reading